Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison
Top Cited Papers
- 1 May 2002
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 359 (9319) , 1715-1720
- https://doi.org/10.1016/s0140-6736(02)08652-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture SurgeryNew England Journal of Medicine, 2001
- Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee SurgeryNew England Journal of Medicine, 2001
- A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis after Total Hip ReplacementNew England Journal of Medicine, 2001
- Mortality after total hip replacement: 0-10-year follow-up of 39,543 patients in the Norwegian Arthroplasty RegisterActa Orthopaedica, 2000
- Comparison of two low-molecular-weight heparins for the prevention of postoperative venous thromboembolism after elective hip surgeryBlood Coagulation & Fibrinolysis, 1998
- A Comparison of Recombinant Hirudin with a Low-Molecular-Weight Heparin to Prevent Thromboembolic Complications after Total Hip ReplacementNew England Journal of Medicine, 1997
- Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393The Lancet, 1996
- The Unique Antithrombin III Binding Domain of Heparin: A Lead to New Synthetic AntithromboticsAngewandte Chemie International Edition in English, 1993
- The inhibition of the generation of thrombin and the antithrombotic effect of a pentasaccharide with sole anti-factor Xa activityThrombosis Research, 1988
- Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous HeparinNew England Journal of Medicine, 1988